For the report, researchers analyzed Nielsen data on television, magazine, radio, newspaper, business-to-business, outdoor and cinema media spend. The analysis did not include digital spend.
Here are the 10 drugmakers that spent the most on direct-to-consumer ads in 2016, according to the report.
1. Pfizer — $1.19 billion
2. Bristol-Myers Squibb — $458 million
3. AbbVie — $433 million
4. Eli Lilly — $414 million
5. Allergan — $352 million
6. Johnson & Johnson — $291 million
7. Merck — $285 million
8. Novartis — $254 million
9. AstraZeneca — $225 million
10. Novo Nordisk — $206 million
More articles on supply chain:
4 reasons supply chain managers could one day become CEOs
Can employers lower drug spending by limiting PBM involvement in health plans? 4 thoughts
5 trends shaping today’s supply chain industry
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
